Company intelligence / Profile preview

Guska

Montevideo, Montevideo, Uruguay
Ownership
Private
Development stage
Other
01

Overview

Guska is a biotech startup developing next-generation cancer immunotherapies based on engineered synthetic RNA oncolytic viruses. Their proprietary platform uses AI-driven design to enhance tumor specificity and safety, including genetic attenuation to prevent reversion to virulence. The company has demonstrated promising preclinical results in patient-derived xenograft models for pancreatic and lung cancers. They are expanding their pipeline and seeking partnerships as they approach IND-enabling studies, with their next major milestone expected after securing a seed round in Q2 2026.

Therapeutic areas
Oncology
Modalities
Oncolytic virus therapySynthetic RNA oncolytic virusNanoparticle (nano lipid particle delivery)
Industry
Biotech
02

Partnerships

Supported by Lab+ Company Builder at Institut Pasteur Montevideo; seeking further strategic partnerships

Beyond the preview

Go deeper on Guska.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guska.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call